Global Pulmonary Drug Delivery Devices Market to Grow at a CAGR of US$43.05 Bn During the Period 2016 – 2024
The global pulmonary drug delivery devices market demonstrates a high degree of competition between GlaxoSmithKline Plc, Boehringer Ingelheim GmbH, AstraZeneca Plc, Teva Pharmaceutical Industries Ltd., and Merck & Co. Inc. states a new research report by Transparency Market Research. With the top five players accounting for more than 67%, the market exhibits a largely consolidated structure.
View full press release